<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Motif Bio plc

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Motif Bio plc

    Motif Bio is a clinical stage biopharmaceutical company developing novel antibiotics to treat patients with serious and life-threatening infections caused by multi-drug resistant bacteria. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Graham Lumsden
    • FOUNDED
      2003
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Athersys, Inc.

    Athersys, Inc.

    We are an international biotechnology company that is focused in the field of rege...

    We are an international biotechnology company t...

    Filing Type:    PU
    United Therapeutics Corporation

    United Therapeutics Corporation

    United Therapeutics Corporation focuses on the strength of a balanced, value-creat...

    United Therapeutics Corporation focuses on the ...

    Filing Type:    PU
    Cara Therapeutics, Inc.

    Cara Therapeutics, Inc.

    Cara Therapeutics is a clinical-stage biopharmaceutical company focused on develop...

    Cara Therapeutics is a clinical-stage biopharma...

    Filing Type:    PU
    Sol-Gel Technologies Ltd.

    Sol-Gel Technologies Ltd.

    Sol-Gel is a clinical-stage specialty pharmaceutical company focused on developing...

    Sol-Gel is a clinical-stage specialty pharmaceu...

    Filing Type:    PU
    Aimmune Therapeutics, Inc.

    Aimmune Therapeutics, Inc.

    Aimmune Therapeutics, Inc. (Nasdaq: AIMT), is a clinical-stage biopharmaceutical c...

    Aimmune Therapeutics, Inc. (Nasdaq: AIMT), is a...

    Filing Type:    PU
    Revance Therapeutics, Inc.

    Revance Therapeutics, Inc.

    Revance Therapeutics is a Silicon Valley-based biotechnology company, pioneering n...

    Revance Therapeutics is a Silicon Valley-based ...

    Filing Type:    PU
    Innovation Pharmaceuticals Inc.

    Innovation Pharmaceuticals Inc.

    Established in 2007, and headquartered in Wakefield, Massachusetts, Innovation Pha...

    Established in 2007, and headquartered in Wakef...

    Filing Type:    PU
    Tetraphase Pharmaceuticals, Inc.

    Tetraphase Pharmaceuticals, Inc.

    Since the company’s inception, Tetraphase has developed a robust antibiotics pla...

    Since the company’s inception, Tetraphase has...

    Filing Type:    PU
    Melinta Therapeutics, Inc.

    Melinta Therapeutics, Inc.

    Melinta Therapeutics, Inc. is dedicated to saving lives threatened by the global p...

    Melinta Therapeutics, Inc. is dedicated to savi...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.